Phase I Trial of Pbi-shRNA EWS/FLI1 Type 1 Lipoplex (LPX) in Subjects With Advanced Ewing's Sarcoma

Trial Profile

Phase I Trial of Pbi-shRNA EWS/FLI1 Type 1 Lipoplex (LPX) in Subjects With Advanced Ewing's Sarcoma

Recruiting
Phase of Trial: Phase I

Latest Information Update: 12 Oct 2016

At a glance

  • Drugs Bi shRNAEWS-FLI-Type-1-LPX (Primary)
  • Indications Ewing's sarcoma
  • Focus Adverse reactions
  • Sponsors Strike Bio
  • Most Recent Events

    • 03 Oct 2016 Status changed from not yet recruiting to recruiting.
    • 22 Jul 2016 Planned primary completion date changed from 1 May 2018 to 1 Sep 2018.
    • 22 Jul 2016 Planned initiation date changed from 1 May 2016 to 1 Sep 2016.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top